# OnCo record nct05377996 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05377996/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05377996", "NCT05377996" ;
  schema:name "A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors"@en ;
  schema:description "A phase 1/2 trial of Emi-Le in triple-negative breast cancer, endometrial cancer, ovarian cancer and salivary gland cancers, run by Day One Biopharmaceuticals, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05377996/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05377996> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2022-08-15" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/salivary-gland/>, <https://onco.cc/cancers/mucoepidermoid-carcinoma/> ;
  onco:companies <https://onco.cc/companies/day-one-biopharmaceuticals/> .